Clinical Trial Update: Maintenance Therapy With Histamine Dihydrochloride and Interleukin-2 in Adult Acute Myeloid Leukemia (AML) Patients With Measurable Minimal Residual Disease (MRD)- a Non-interventional Study (NIS)

View source ↗

Summary

The document reports a terminated non-interventional study evaluating maintenance therapy with histamine dihydrochloride and interleukin-2 in adults with acute …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Histamine dihydrochloride (histamine dihydrochloride)
• Interleukin-2 (interleukin-2)

Snippet

Sponsor: University of Ulm | Conditions: Acute Myeloid Leukemia | Status: TERMINATED